What a buyer sees
GENESIS PHARMACEUTICALS LIMITED
Wholesale of pharmaceutical goods · Harrow · 03850289
11staff · FY2023
27years trading
56oldest owner on file
£382kcash at bank
Your turnover is on public record
filed£51Mfor the year to 2023
Unusual at this size, and it works in your favour: a buyer is reading your number rather than guessing at one.
What your filings show moving
Staff11
202211 → 112023
Cash at bank£382k
2022£320k → £382k2023
How you sit in your trade
slowest tenth typical fastest tenth youSales per employee£4,594,146above almost all
£262,123£642,600£1,529,295
Debtor daysdays104above almost all
3555103
Creditor daysdays78
103090
Stock daysdaysnot on your filings
1741104
Each spread is companies in the same trade and size that did publish a turnover. Creditor days are shown but not marked: neither end of that one is plainly good.
What a buyer would ask 3
- The newest accounts on file are 32 months oldAnyone looking at the company today is reading a year that has already ended. Whatever has improved since is invisible.
- Debtor days run high for your tradeYours is 104 against 55 for the middle of 35 comparable companies. That gap is working capital a buyer has to fund on day one, and it comes off the price.
- No website on file against the companyThe first thing anyone does with a company number is look for the business behind it. Finding nothing is its own answer.
What a buyer would like 3
- 27 years of trading on fileLongevity is the cheapest evidence there is that the business is not one contract.
- Sales per employee better than three quarters of your tradeYours is 4,594,146 against 642,600 for the middle of 41 comparable companies.
- A board that has been together ten years or moreContinuity a buyer does not have to take on trust.
What the register says
Owners
- 56since 2022
Directors
- since 1999
- 56since 1999
- 70since 2010
| Year to | Turnover | Staff | Cash |
|---|---|---|---|
| 2023-12-31 | £51M | 11 | £382k |
| 2022-12-31 | £53M | 11 | £320k |
A rough bracket, and why it is only that
0.35–0.55× sales£18M£28M
The turnover range is fitted on UK companies that did file one. The multiple is a published sector average from Dutch mid-market deals, not from your own numbers and not from your own market. Treat this as the opening bracket of a conversation, not a valuation.